U.S. Markets open in 1 hr 44 mins

Eli Lilly and Company (LLY)

NYSE - NYSE Delayed Price. Currency in USD
337.65+3.05 (+0.91%)
At close: 04:03PM EDT
339.50 +1.85 (+0.55%)
Pre-Market: 07:34AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close334.60
Bid337.00 x 1000
Ask350.00 x 1100
Day's Range334.71 - 338.83
52 Week Range276.83 - 375.25
Avg. Volume3,184,510
Market Cap320.828B
Beta (5Y Monthly)0.35
PE Ratio (TTM)50.55
EPS (TTM)6.68
Earnings DateApr 27, 2023
Forward Dividend & Yield4.52 (1.32%)
Ex-Dividend DateFeb 14, 2023
1y Target Est388.56
  • Reuters

    Boehringer's profit up 1.4% as Jardiance gains offset impairments

    German unlisted drugmaker Boehringer Ingelheim said on Wednesday its operating income rose 1.4% in 2022, as more prescriptions of diabetes drug Jardiance trumped higher energy costs and the effect of write-downs on development projects. Family-owned Boehringer said in its annual report that full-year operating income came in at 4.77 billion euros ($5.17 billion), up from 4.71 billion a year earlier. The Jardiance group of products, managed in a partnership with Eli Lilly, had 5.8 billion euros in sales, a currency-adjusted surge of 39.1%.

  • Zacks

    Eli Lilly (LLY) Gains As Market Dips: What You Should Know

    In the latest trading session, Eli Lilly (LLY) closed at $337.65, marking a +0.91% move from the previous day.

  • Motley Fool

    Is Eli Lilly or Bristol Myers Squibb the Better Value Stock to Buy Right Now?

    While growth stocks boomed in the era of easy money, value stocks have returned to form as the market's top performers in the current high interest rate environment. Now, value comes in many forms, such as a highly dependable dividend, an economically insensitive revenue stream, the quality of a company's management team, long-term growth drivers, and/or an attractive valuation. In the present risk-averse market, the most highly prized aspects of value stocks appear to be the dependability of a company's dividend, along with its ability to generate strong free cash flows regardless of the state of the broader economy.